Skip to content
healthcare.dev

Deferasirox

NDC 31722-013, Deferasirox, tablet, film coated, from Camber Pharmaceuticals, Inc..

Product NDC
31722-013
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214341
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX360 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
31722-013-303172200133030 TABLET, FILM COATED in 1 BOTTLE (31722-013-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/65453013-c360-4835-8358-2a278a4a32db
  • NADAC price for package 31722001330

    GET /v1/drugs/nadac/31722001330

Use it

Look up 31722-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.